Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Paula Trahan-Rieger"'
Autor:
Paula Trahan Rieger, Pearl Moore
Publikováno v:
Seminars in Oncology Nursing. 18:276-289
Objectives To review the role of professional organizations in advocacy using the ONS as a paradigm. Data Sources Professional journal, organization publications, personal experiences, and internet websites. Conclusions Professional organizations are
Autor:
Anu Chittenden, Gordon B. Mills, Gail E. Tomlinson, Judy Garber, Laura J. Esserman, Beth Crawford, Connie A Roche, Jennifer R. Klemp, Amy Stucky, Kevin S. Hughes, Patricia A. Ganz, Shelly Cummings, Kristin C Smith, Olufunmilayo I. Olopade, David M. Euhus, Carol J. Fabian, Linda Robinson, Paula Trahan Rieger, Joyce Seldon
Publikováno v:
JNCI: Journal of the National Cancer Institute. 94:844-851
Background Because BRCA gene mutation testing is costly, occasionally uninformative, and frequently associated with ethical and legal issues, careful patient selection is required prior to testing. Estimation of BRCA gene mutation probability is an i
Autor:
Paula Trahan Rieger
Publikováno v:
Cancer. 92:1733-1736
At The University of Texas M. D. Anderson Cancer Center, a multidisciplinary workgroup was assembled to review issues, current research, and areas of future research related to the assessment and epidemiology of cancer-related fatigue. Interactive di
Autor:
Paula Trahan Rieger
Publikováno v:
American Journal of Nursing. 100:87-92
Autor:
Paula Trahan Rieger, Susan T. Tinley
Publikováno v:
Gastroenterology Nursing. 23:28-39
Most nurses will care for and provide health information about cancer to a patient at some point in their careers. Cancer care will change dramatically in the coming years as a result of the translation of information gained from the Human Genome Pro
Publikováno v:
American Journal of Medical Genetics. 98:3-12
This study evaluated oncology nurses' knowledge of cancer genetics and related topics, and identified current practice patterns and perceived educational needs in this area. A 54-item study questionnaire was mailed to a random sample of 1,200 Oncolog
Autor:
Kalpana Mujoo, Sewa S. Legha, Omar Eton, Merrick I. Ross, James L. Murray, Antonio C. Buzaid, Saroj Vadhan-Raj, Eugenie S. Kleinerman, Lora Thompson, Mansoor N. Saleh, Michael G. Rosenblum, M. B. Khazaeli, Paula Trahan Rieger, Shu Fang Jia
Publikováno v:
Journal of Immunotherapy. 19:206-217
We performed a phase Ia/Ib trial of chimeric anti-GD2 monoclonal antibody 14.18 (ch14.18) in combination with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) to determine the maximum tolerated dose as well as immunologic
Autor:
Paula Trahan Rieger
Publikováno v:
Journal of Wound, Ostomy and Continence Nursing. 21:111-119
In the United States, more than 149,000 new cases of colorectal cancer are expected in 1994. Surgery remains the most effective method of treatment for this disease. Because these operations often result in formation of an ostomy, ET nurses frequentl
Autor:
V. A. Bhadkamkar, Hua‐Zhong ‐Z Zhang, Joan E. Cunningham, Donald A. Podoloff, L. P. Kasi, Daniel J. Macey, James L. Murray, Paula Trahan Rieger, Michael G. Rosenblum, Jeffrey Schlom
Publikováno v:
Cancer. 73:1057-1066
Background. Radiolabeled CC49, a second generation high affinity monoclonal antibody (MoAb) reactive with tumor-associated glycoprotein 72 (TAG72) has undergone previous Phase I testing in patients with colon cancer. Based on this report, the authors
Autor:
Paula Trahan Rieger, Joyce A. Marrs
Publikováno v:
Clinical journal of oncology nursing. 10(4)
The media seem to announce a new scientific discovery related to cancer daily. Oncology nurses are challenged to keep up with the explosion of new knowledge and to understand how it ultimately relates to the care of patients with cancer. A framework